Skip to main content

Advertisement

Log in

Symptoms Suggestive of Gastroparesis in a Community-Based Cohort of European Americans and African Americans with Type 2 Diabetes Mellitus

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Although gastroparesis is seen in patients with type 2 diabetes mellitus (T2DM), the prevalence of symptoms suggestive of gastroparesis in patients with T2DM is unknown, particularly among African Americans.

Aims

To determine the prevalence of symptoms associated with gastroparesis in a large community-based population of European Americans and African Americans with T2DM.

Methods

Individuals with T2DM in the Diabetes Heart Study were asked to complete the gastroparesis cardinal symptom index (GCSI) and other GI-related questionnaires. GCSI total score ≥ 18 represented moderate or worse symptoms suggestive of gastroparesis.

Results

A total of 1253 participants (700 female, 553 male) completed the GCSI: 750 were European American and 503 African American. GCSI scores ≥ 18 were recorded in 72 participants: 38 (5%) of European Americans and 34 (7%) of African Americans. The average GCSI was 24.1 in European Americans and 24.6 in African Americans, indicating moderate to severe symptoms. Compared to European Americans with GCSI scores ≥ 18, African Americans were younger (59.4 vs. 53.3 years, p = 0.004), had earlier onset of T2DM (46.3 vs. 40.1 years, p = 0.01), higher HbA1c (7.6 vs. 9.1, p = 0.0009), underwent fewer upper endoscopies (55.3% vs. 26.5%, p = 0.02), and had more anxiety and depression (p < 0.001).

Conclusions

Moderate or greater symptoms suggestive of gastroparesis are present in 5–7% of European and African American patients with T2DM in community-based populations. Symptoms suggestive of gastroparesis may be underappreciated in patients with T2DM and account for upper gastrointestinal symptoms, unexplained glycemic control issues, and decreased quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Koch KL, Calles-Escandan J. Diabetic gastroparesis. Gastroenterol Clin North Am. 2015;44:39–57.

    Article  Google Scholar 

  2. Kofod-Andersen K, Tarnow L. Prevalence of gastroparesis-related symptoms in an unselected cohort of patients with type 1 diabetes. J Diabetes Complicat. 2012;26:89–93.

    Article  Google Scholar 

  3. Spangeus A, El-Salhy M, Suhr O, Eriksson J, Lithner F. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients. Scand J Gastroenterol. 1999;34:1196–1202.

    Article  CAS  Google Scholar 

  4. Ricci JA, Siddique R, Steward WF, Sandler RS, Sloan S, Farup CE. Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. Scand J Gastroenterol. 2000;35:152–159.

    Article  CAS  Google Scholar 

  5. Dickman R, Kislov J, Boaz M, et al. Prevalence of symptoms suggestive of gastroparesis in a cohort of patients with diabetes mellitus. J Diabetes Complicat. 2013;27:376–379.

    Article  Google Scholar 

  6. Koch KL, Hasler WL, Yates KP, et al. Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1vs type 2 diabetes. Neurogastroenterol Motil. 2016;28:1001–1015.

    Article  CAS  Google Scholar 

  7. Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995–2004. Am J Gastroenterol. 2008;103:313–322.

    Article  Google Scholar 

  8. Intagliata N, Koch KL. Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment. Curr Gastroenterol Rep. 2007;9:270–279.

    Article  Google Scholar 

  9. Janatuinen E, Pikkarainen P, Laakso M, Pyörälä K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol. 1993;28:427–432.

    Article  CAS  Google Scholar 

  10. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97:604–611.

    Article  Google Scholar 

  11. Parkman HP, Van Natta ML, Abeil TL, et al. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial. JAMA. 2013;310:2640–2649.

    Article  CAS  Google Scholar 

  12. Cassilly DW, Wang YR, Friedenberg FK, Nelson DB, Maurer AH, Parkman HP. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion. 2008;78:144–151.

    Article  Google Scholar 

  13. Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol. 2008;103:416–423.

    Article  CAS  Google Scholar 

  14. Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004;13:833–844.

    Article  Google Scholar 

  15. Leidy NK, Farup C, Rentz AM, Ganoczy D, Koch KL. Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI). Dig Dis Sci. 2000;45:1172–1179. https://doi.org/10.1023/a:1005558204440.

    Article  CAS  PubMed  Google Scholar 

  16. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Psychol Assess. 1977;1:385–401.

    Google Scholar 

  17. Kato N, Kinugawa K, Shiga T, et al. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction. J Cardiol. 2012;60:23–30.

    Article  Google Scholar 

  18. Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2011;29:413–420.

    Article  Google Scholar 

  19. Crameri A, Schuetz C, Andreae A, et al. The brief symptom inventory and the outcome questionnaire-45 in the assessment of the outcome quality of mental health interventions. Psychiatry J. 2016;2016:7830785.

    Article  Google Scholar 

  20. Derogatis LR, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med. 1983;13:595–605.

    Article  CAS  Google Scholar 

  21. DiBaise JK, Patel N, Noelting J, Dueck AC, Roarke M, Crowell MD. The relationship among gastroparetic symptoms, quality of life, and gastric emptying in patients referred for gastric emptying testing. Neurogastroenterol Motil. 2016;28:234–242.

    Article  CAS  Google Scholar 

  22. Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589–1591.

    Article  Google Scholar 

  23. Centers for Disease Control and Prevention. Diabetes Report Card 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2015.

  24. Stanghellini V, Tack J. Gastroparesis: separate entity or just a part of dyspepsia? Gut. 2014;63:1972–1978.

    Article  Google Scholar 

  25. Cherian D, Sachdeva P, Fisher RS, Parkman HP. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol. 2010;8:676–681.

    Article  Google Scholar 

  26. Parkman HP, Yamada G, Van Natta ML, et al. Ethnic, racial, and sex differences in etiology, symptoms, treatment, and symptom outcomes of patients with gastroparesis. Clin Gastroenterol Hepatol. 2019;17:1489–1499.

    Article  Google Scholar 

  27. Friedenberg FK, Kowalczyk M, Parkman HP. The influence of race on symptom severity and quality of life in gastroparesis. J Clin Gastroenterol. 2013;47:757–761.

    Article  Google Scholar 

  28. Homko C, Siraj ES, Parkman HP. The impact of gastroparesis on diabetes control: patient perceptions. J Diabetes Complicat. 2016;30:826–829.

    Article  Google Scholar 

  29. Almogbel RA, Alhussan FA, Alnasser SA, Algeffari MA. Prevalence and risk factors of gastroparesis-related symptoms among patients with type 2 diabetes. Int J Health Sci (Qassim). 2016;10:397–404.

    Article  Google Scholar 

  30. Calles-Escandón J, Koch KL, Hasler WL, et al. GpCRC Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: an open-label pilot prospective study. PLoS One. 2018;13:e0194759.

    Article  Google Scholar 

  31. Jung HK, Choung RS, Locke GR III, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–1233.

    Article  Google Scholar 

  32. Dickman R, Wainstein J, Glezerman M, Niv Y, Boaz M. Gender aspects suggestive of gastroparesis in patients with diabetes mellitus: a cross-sectional survey. BMC Gastroenterol. 2014;14:34.

    Article  Google Scholar 

  33. Samsom M, Vermeijden JR, Smout AJ, et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care. 2003;26:3116–3122.

    Article  CAS  Google Scholar 

  34. Gangula PR, Sekhar KR, Mukhopadhyay S. Gender bias in gastroparesis: is nitric oxide the answer? Dig Dis Sci. 2011;56:2520–2527. https://doi.org/10.1007/s10620-011-1735-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Chan GC, Divers J, Russell GB, et al. FGF23 concentration and APOL1 genotype are novel predictors of mortality in African Americans with type 2 diabetes. Diabetes Care. 2018;41:178–186.

    Article  CAS  Google Scholar 

  36. Raffield LM, Hsu FC, Cox AJ, Carr JJ, Freedman BI, Bowden DW. Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: diabetes heart study. Diabetol Metab Syndr. 2015;28:58.

    Article  Google Scholar 

  37. Celeng C, Maurovich-Horvat P, Ghoshhajra BB, Merkely B, Leiner T, Takx RA. Prognostic value of coronary computed tomography angiography in patients with diabetes: a meta-analysis. Diabets Care. 2016;39:1274–1280.

    Article  Google Scholar 

  38. Woodhouse S, Hebbard G, Knowles SR. Psychological controversies in gastroparesis: a systematic review. World J Gastroenterol. 2017;23:1298–1309.

    Article  Google Scholar 

  39. Hasler WL, Parkman HP, Wilson LA, et al. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol. 2010;105:2357–2367.

    Article  Google Scholar 

  40. Almogbel RA, Alhussan FA, Alnasser SA, Algeffari MA. Prevalence and risk factors of gastroparesis-related symptoms among patients with type 2 diabetes. Int J Health Sci (Qassim). 2016;10:397–404.

    Article  Google Scholar 

  41. Anudeep V, Vinod KV, Pandit N, et al. Prevalence and predictors of delayed gastric emptying among Indian patients with longstanding type 2 diabetes mellitus. Indian J Gastroenterol. 2016;35:385–392.

    Article  Google Scholar 

  42. Cassilly DW, Wang YR, Friedenberg FK, Nelson DB, Maurer AH, Parkman HP. Symptoms if gastroparesis: use of the Gastroparesis Cardinal Symptoms Index in symptomatic patients referred for gastric emptying scintigraphy. Digestion. 2008;78:144–151.

    Article  Google Scholar 

Download references

Funding

This funding was provided by National Institutes of Health (Grant Nos. NIH R01 HL92301 (DWB); R01 HL67348 (DWB) and R01 DK071891 (BIF)).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Landon K. Brown.

Ethics declarations

Conflict of interest

All authors have no conflicts of interest or financial disclosures to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brown, L.K., Xu, J., Freedman, B.I. et al. Symptoms Suggestive of Gastroparesis in a Community-Based Cohort of European Americans and African Americans with Type 2 Diabetes Mellitus. Dig Dis Sci 65, 2321–2330 (2020). https://doi.org/10.1007/s10620-019-05974-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-019-05974-z

Keywords

Navigation